Twenty lives and $440,000 over a year. For every 1,000 patients. That’s what CYP2C19 pharmacogenetic testing could save if used to help prescribe clopidogrel (Plavix), prasugrel or ticagrelor to specific…
Read More
The evidence for expanded use of pharmacogenetic data to help inform heart medication prescribing just got stronger. A comprehensive review of the scientific literature on pharmacogenomics and heart medications found…
Read More
By Rachel Sass, PharmD Should providers increase the clopidogrel dose in patients with decreased functioning CYP2C19 enzymes? Clopidogrel (Plavix) is one of the most well studied medications in pharmacogenetics. Clopidogrel…
Read More
